MultivisionDx builds AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancers. Our computer vision technology integrates unique biological and spatial features of the tumor and its microenvironment, flagging patients at risk of therapy failure in standard-of-care treatments. This approach provides clinicians with actionable insights for tailoring the most effective treatment strategies for individual patients.
Built on award-winning research at the University of Helsinki and published in Cell, the technology establishes a new standard in tumor profiling.